10 months ago
SRPT
AnalystsAndrew TsaiAndrew Tsai's Stock Forecasts
AnalystsAndrew Tsai
Analyst Ranking
Bottom 7%
#4651 out of 4980 analysts
Average Return
-12.29%
Win Rate
43%9 out of 21
Risk vs Reward
Poor
Good
Andrew Tsai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cerevel Therapeutics Holdings IncCERE | +139.30% | $14.20 | $33.98 | 2020-11-22 - 2021-11-22 | Strong Buy |
Sarepta Therapeutics IncSRPT | +57.61% | $12.88 | $20.30 | 2025-07-23 - 2025-08-14 | Strong Buy |
Xenon Pharmaceuticals IncXENE | +41.19% | $13.11 | $18.51 | 2020-05-31 - 2021-06-01 | Strong Buy |
Intra Cellular Therapies IncITCI | +33.63% | $35.30 | $47.17 | 2021-09-19 - 2022-09-19 | Strong Buy |
Stoke Therapeutics IncSTOK | +29.88% | $13.22 | $17.17 | 2025-07-17 - 2025-08-14 | Strong Buy |
Andrew Tsai Analyst Color
Get additional color on Andrew Tsai's coverage of popular stocks
Andrew Tsai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 3 | Strong Buy | $35.00 | +72.41% | Maintains | 22 days ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $30.00 | +74.72% | Initiates Coverage On | a month ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $70.00 | +36.77% | Initiates Coverage On | a month ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $110.00 | +4.49% | Maintains | 2 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Hold | $2.50 | -17.49% | Downgrades | 3 months ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $200.00 | +83.91% | Initiates Coverage On | 4 months ago |
Ke Holdings IncBEKE | 2 | Strong Buy | $27.00 | +46.82% | Maintains | 5 months ago |
Marinus Pharmaceuticals IncMRNS | 1 | Hold | $0.50 | -9.09% | Downgrades | 10 months ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $13.00 | +2,041.68% | Upgrades | a year ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | N/A | Downgrades | a year ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | a year ago |
Vistagen Therapeutics IncVTGN | 2 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $3.00 | N/A | Initiates Coverage On | 2 years ago |
Athira Pharma IncATHA | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $70.00 | N/A | Maintains | 4 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 4 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 5 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $23.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.